The current and future value of mRNA vaccines and therapeutics

Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies

Leveraging the immunological diversity of the PentaMice® platform for COVID-19 antibody discovery

Antibody-based drug discovery at the speed of light

The benefits of end-to-end formulation and fill-finish of biologics